Tag: Drug prices

May 22, 2026

STAT+: EU and US advisers split over AstraZeneca breast cancer drug

May 18, 2026

US Biotech Divided Over China Partnerships Amid FDA Leadership Shakeup

May 18, 2026

Supreme Court Declines Drugmaker Challenge to Medicare Drug Price Negotiations

May 1, 2026

FDA Names Acting CBER Head, New Bespoke Medicine Push, and J. Craig Venter’s Legacy

April 23, 2026

Trump Announces Drug Pricing Deal With Regeneron, Including Medicaid Price Cuts, $225 Praluent and $27B U.S. Investment

April 18, 2026

Record Biotech IPO and the Future of Obesity Drugs Beyond GLP-1

April 14, 2026

Congress Returns to Packed Health Care Agenda After Recess

April 14, 2026

Ben Sasse Praises Revolution Medicines Pancreatic Cancer Pill for Extending Life

April 13, 2026

Biotech Update: Revolution Medicines, GSK and Spyre Therapeutics Latest News

April 10, 2026

CAR-T Therapy Gains in Autoimmune Disease and FDA Withdraws GSK Leucovorin